Extramedullary relapse in RARA rearrangement-negative acute promyelocytic leukemia successfully treated in combination with chemotherapy, local radiotherapy, and cord blood transplantation

J Pediatr Hematol Oncol. 2015 May;37(4):e234-7. doi: 10.1097/MPH.0000000000000293.

Abstract

RARA rearrangement-negative acute promyelocytic leukemia (APL) is uncommon, and its extramedullary relapse is extremely rare. We report a 5-year-old girl with RARA rearrangement-negative APL, which recurred solely at the external auditory canal and mastoid air cells. She was successfully treated with chemotherapy, local radiotherapy, and unrelated cord blood transplantation. She has maintained complete remission for 24 months after transplantation. The clinical features and our therapeutic strategy in this patient will provide valuable information for extramedullary relapse of RARA rearrangement-negative APL.

Publication types

  • Case Reports

MeSH terms

  • Allografts
  • Arsenic Trioxide
  • Arsenicals / therapeutic use
  • Combined Modality Therapy
  • Cord Blood Stem Cell Transplantation*
  • Female
  • Gene Rearrangement*
  • Humans
  • Infant
  • Leukemia, Promyelocytic, Acute / genetics
  • Leukemia, Promyelocytic, Acute / therapy*
  • Oxides / therapeutic use
  • Receptors, Retinoic Acid / genetics*
  • Recurrence
  • Retinoic Acid Receptor alpha

Substances

  • Arsenicals
  • Oxides
  • RARA protein, human
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • Arsenic Trioxide